menu
    • menu

    Company profile for ExCellThera

    NEW Drugs in Dev: 3
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ExCellThera is a clinical stage biotechnology company delivering molecules and bioengineering solutions to expand blood stem and immune cells for therapeutic use. ExCellThera’s lead technology, ECT-001, combines a proprietary small molecule, UM171, and an optimized culture system. In pursuit of better treatments for patients, the company is building out its portfolio of products, as well as supporting best-in-class clinical ...
    ExCellThera is a clinical stage biotechnology company delivering molecules and bioengineering solutions to expand blood stem and immune cells for therapeutic use. ExCellThera’s lead technology, ECT-001, combines a proprietary small molecule, UM171, and an optimized culture system. In pursuit of better treatments for patients, the company is building out its portfolio of products, as well as supporting best-in-class clinical trials.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ExCellTheraCanada Flag
    Country
    Country
    Canada
    Address
    Address
    2950 chemin de Polytechnique Montréal, Québec H3T 1J4
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://excellthera.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/excellthera
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/excellthera?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zemcelpro (Dorocubicel) Receives NUB Status 1 In Germany
    Zemcelpro (Dorocubicel) Receives NUB Status 1 In Germany

    16 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/zemcelpro-dorocubicel-receives-nub-status-1-in-germany-302688429.html

    PR NEWSWIRE
    16 Feb 2026
    Share Share
    ExCellThera's Blood Cancer Cell Therapy Zemcelpro Earns EU Nod
    ExCellThera's Blood Cancer Cell Therapy Zemcelpro Earns EU Nod

    27 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/zemcelpro-um171-cell-therapy-receives-ec-authorization-as-the-first-and-only-cell-therapy-for-blood-cancer-patients-without-access-to-suitable-donor-cells-302539246.html

    PR NEWSWIRE
    27 Aug 2025
    Share Share
    Zemcelpro Gets Positive CHMP Opinion for Blood Cancer Treatment
    Zemcelpro Gets Positive CHMP Opinion for Blood Cancer Treatment

    19 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/zemcelpro-um171-cell-therapy-receives-positive-chmp-opinion-for-treatment-of-blood-cancer-patients-without-access-to-suitable-donor-cells-302486367.html

    PR NEWSWIRE
    19 Jun 2025
    Share Share
    ExCellThera’s UM171 Cell Therapy Accepted for Accelerated Assessment by EMA
    ExCellThera’s UM171 Cell Therapy Accepted for Accelerated Assessment by EMA

    25 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/25/2903656/0/en/ExCellThera-Announces-EMA-s-Acceptance-under-Accelerated-Assessment-of-Market-Authorisation-Application-MAA-for-UM171-Cell-Therapy-for-Patients-with-Hematological-Malignancies-who-.html

    GLOBENEWSWIRE
    25 Jun 2024
    Share Share
    ExCellThera to Conduct Meetings During the J.P. Morgan 42nd Annual Conference
    ExCellThera to Conduct Meetings During the J.P. Morgan 42nd Annual Conference

    02 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/01/02/2802574/0/en/ExCellThera-to-Conduct-Investor-Meetings-During-the-J-P-Morgan-42nd-Annual-Healthcare-Conference-and-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    02 Jan 2024
    Share Share
    ExCellThera Announces Positive Phase 2 Study Results from UM171 Cell Therapy
    ExCellThera Announces Positive Phase 2 Study Results from UM171 Cell Therapy

    12 Dec 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/12/12/2794600/0/en/ExCellThera-Announces-Positive-Phase-2-Study-Results-from-UM171-Cell-Therapy-in-Patients-with-High-risk-Leukemias-and-Myelodysplasias-at-American-Society-of-Hematology-ASH-2023-Ann.html

    GLOBENEWSWIRE
    12 Dec 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search